Santen Pharmaceuticals-backed Clearside, which has raised $48m altogether, is developing a range of treatments for blinding eye diseases.

Goldman Sachs has contributed a $20m extension to a Tasly Pharmaceuticals-backed round that achieved a first close at $35m in September.

Salesforce-backed Evariant has raised almost $70m in total and will use the Goldman Sachs-led series C round to drive recruitment.

HBI Solutions will fund the growth of its healthcare analytics technology business with $12.6m of series A funding, while investor Wonders Information helps it enter China.

Six social impact startups have completed the Singapore Telecommunications-backed Enabling Change incubator program, with SingTel investing $7,000 in each.

University College London establishes Athena Vision to commercialise gene therapies for eye diseases.

Fitness coaching app Goqii has received funding in a round co-led by mobile IT technology provider Cheetah Mobile and venture firm New Enterprise Associates.